What is the nonverbal communication of depression? Assessing expressive differences between depressive patients and healthy volunteers during clinical interviews

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.238, p.636-644, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: It is unclear if individuals with Major Depressive Disorder (MDD) present different nonverbal behavior (NVB) compared with healthy individuals, and also if depression treatments affect NVB. In this study, we compared the NVB of MDD subjects and healthy controls. We also verified how MDD subjects' NVB is affected by depression severity and acute treatments. Methods: We evaluated 100 MDD outpatients and 83 controls. We used a 21-category ethogram to assess the frequency of positive and negative NVB at baseline. MDD subjects were also assessed after eight weeks of treatment (pharmacotherapy or neuromodulation). We used the Wilcoxon signed-rank test to compare the NVB of MDD subjects and controls; beta regression models to verify associations between MDD severity and NVB; the Shapiro-Wilk test to verify changes in NVB after treatment; and logistic regression models to verify NVB associated with treatment response according to the Hamilton depression rating scale. Results: Compared with controls, MDD subjects presented higher levels of six negative NVB (shrug, head and lips down, adaptive hand gestures, frown and cry) and lower levels of two positive NVB (eye contact and smile). MDD subjects' NVB was not associated with depression severity, and did not significantly change after depression treatment. Treatment responders showed more interpersonal proximity at baseline than non-responders. Limitations: Our ethogram had no measure of behavior duration, and we had a short follow-up period. Conclusions: MDD subjects have more negative and less positive social NVB than controls. Their nonverbal behavior remained stable after clinical response to acute depression treatments.
Palavras-chave
Nonverbal communication, Depression, Depressive disorder, Transcranial direct current stimulation, Antidepressive agents, Ethology
Referências
  1. Alpert M, 2001, J AFFECT DISORDERS, V66, P59, DOI 10.1016/S0165-0327(00)00335-9
  2. American Psychiatric A American Psychiatric A, 2013, DIAGNOSTIC STAT MANU
  3. Andersen P. A., 1999, NONVERBAL COMMUNICAT
  4. Andersen P. A., 2006, SAGE HDB NONVERBAL C
  5. Annen S, 2012, J NERV MENT DIS, V200, P26, DOI 10.1097/NMD.0b013e31823e653b
  6. Berry DS, 2000, PERS SOC PSYCHOL B, V26, P278, DOI 10.1177/0146167200265002
  7. Blacker D., 2005, COMPREHENSIVE TXB PS, P929
  8. Bouhuys AL, 2003, NONVERBAL BEHAV CLIN, P233
  9. Brugel S, 2015, PATIENT EDUC COUNS, V98, P1260, DOI 10.1016/j.pec.2015.08.007
  10. Brunoni AR, 2017, NEW ENGL J MED, V376, P2523, DOI 10.1056/NEJMoa1612999
  11. Brunoni A. R., 2016, BR J PSYCHIAT
  12. Brunoni AR, 2015, SAO PAULO MED J, V133, P252, DOI 10.1590/1516-3180.2014.00351712
  13. Burgoon J. K., 2011, SAGE HDB INTERPERSON
  14. Butler EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129651
  15. CAHN DD, 1992, PERCEPT MOTOR SKILL, V74, P1059, DOI 10.2466/PMS.74.4.1059-1064
  16. Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x
  17. Canales JZ, 2017, GAIT POSTURE, V52, P258, DOI 10.1016/j.gaitpost.2016.12.011
  18. Canales JZ, 2010, REV BRAS PSIQUIATR, V32, P375, DOI 10.1590/S1516-44462010000400010
  19. Carneiro AM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0235-3
  20. DEPAULO BM, 1992, PSYCHOL BULL, V111, P203, DOI 10.1037/0033-2909.111.2.203
  21. Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221
  22. EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384
  23. Ellgring H, 1996, J NONVERBAL BEHAV, V20, P83, DOI 10.1007/BF02253071
  24. Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501
  25. Fiquer JT, 2017, PSYCHIAT RES, V250, P59, DOI 10.1016/j.psychres.2017.01.053
  26. Fiquer JT, 2013, J AFFECT DISORDERS, V150, P1114, DOI 10.1016/j.jad.2013.05.002
  27. FISCH HU, 1983, J ABNORM PSYCHOL, V92, P307, DOI 10.1037/0021-843X.92.3.307
  28. FOSSI L, 1984, J NERV MENT DIS, V172, P332, DOI 10.1097/00005053-198406000-00004
  29. Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694
  30. Geerts E, 1996, J AFFECT DISORDERS, V40, P15, DOI 10.1016/0165-0327(96)00037-7
  31. Geerts E, 2006, DEPRESS ANXIETY, V23, P200, DOI 10.1002/da.20162
  32. Goldstein LH, 1996, J FAM PSYCHOL, V10, P60, DOI 10.1037/0893-3200.10.1.60
  33. GROSS JJ, 1995, PERS INDIV DIFFER, V19, P555, DOI 10.1016/0191-8869(95)00055-B
  34. HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278
  35. HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993
  36. HAUSDORFF JM, 2004, BMC PSYCHIATRY, V4, P39, DOI 10.1186/1471-244X-4-39
  37. Hollander M., 1999, NONPARAMETRIC STAT M
  38. JONES IH, 1979, J NERV MENT DIS, V167, P402, DOI 10.1097/00005053-197907000-00002
  39. Kotov R., 2010, AM PSYCHOL ASS
  40. Lavelle M, 2015, ACTA PSYCHIAT SCAND, V131, P197, DOI 10.1111/acps.12319
  41. Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0
  42. Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617
  43. MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23
  44. Martin R, 1999, PERS SOC PSYCHOL B, V25, P1196, DOI 10.1177/0146167299258002
  45. Mast MS, 2007, PATIENT EDUC COUNS, V67, P315, DOI 10.1016/j.pec.2007.03.005
  46. Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
  47. MCCULLAGH P, 1984, EUR J OPER RES, V16, P285, DOI 10.1016/0377-2217(84)90282-0
  48. Messinger DS, 1999, DEV PSYCHOL, V35, P701, DOI 10.1037/0012-1649.35.3.701
  49. Messinger DS, 2002, CURR DIR PSYCHOL SCI, V11, P1, DOI 10.1111/1467-8721.00156
  50. Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c
  51. Mundt JC, 2007, J NEUROLINGUIST, V20, P50, DOI 10.1016/j.jneuroling.2006.04.001
  52. NILSONNE A, 1987, ACTA PSYCHIAT SCAND, V76, P235, DOI 10.1111/j.1600-0447.1987.tb02891.x
  53. Otta E., 1994, SORRISO SEUS SIGNIFI
  54. Pegoraro L. F., 2014, EVOL PSYCHOL, V12
  55. Philippot P., 2003, NONVERBAL BEHAV CLIN
  56. Riggio HR, 2002, J NONVERBAL BEHAV, V26, P195, DOI 10.1023/A:1022117500440
  57. Rosario JL, 2014, J BODYW MOV THER, V18, P540, DOI 10.1016/j.jbmt.2013.12.010
  58. Roter DL, 2006, J GEN INTERN MED, V21, pS28, DOI 10.1111/j.1525-1497.2006.00306.x
  59. Sackeim H. A., 2001, J CLIN PSYCHIAT
  60. SCHELDE T, 1994, ETHOL SOCIOBIOL, V15, P383, DOI 10.1016/0162-3095(94)90010-8
  61. Scott J, 2000, BRIT J PSYCHIAT, V177, P440, DOI 10.1192/bjp.177.5.440
  62. TROISI A, 1990, ACTA PSYCHIAT SCAND, V81, P560, DOI 10.1111/j.1600-0447.1990.tb05499.x
  63. Troisi A, 1999, NEUROSCI BIOBEHAV R, V23, P905, DOI 10.1016/S0149-7634(99)00024-X
  64. Vrij A, 2000, J NONVERBAL BEHAV, V24, P239, DOI 10.1023/A:1006610329284
  65. Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6